Bridgeway Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History

Bridgeway Capital Management’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16M	Buy	108,005 +25,000	+30%	+$204K	0.02%	711
2026 Q1	$510K	Hold	83,005	–	–	0.01%	823
2025 Q4	$639K	Buy	83,005 +52,305	+170%	+$429K	0.01%	779
2025 Q3	$287K	Buy	30,700 +6,500	+27%	+$56.3K	0.01%	938
2025 Q2	$201K	Buy	+24,200	New	+$166K	﹤0.01%	961
2023 Q4	–	Sell	-34,200	Closed	-$257K	–	1381
2023 Q3	$257K	Hold	34,200	–	–	0.01%	1044
2023 Q2	$302K	Hold	34,200	–	–	0.01%	1044
2023 Q1	$285K	Hold	34,200	–	–	0.01%	1024
2022 Q4	$328K	Buy	+34,200	New	+$303K	0.01%	971

Other funds holding FENC

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCA

Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Bridgeway Capital Management's FENC Position: Q2 2026 in Review

Bridgeway Capital Management increased its Fennec Pharmaceuticals (FENC) stake by 30% in Q2 2026, buying an estimated $204K and bringing the position to 108,005 shares worth $1.16M. The position accounts for 0.02% of the portfolio, ranked #711.

Bridgeway Capital Management first reported a position in FENC in Q4 2022 and has held it in 9 quarters since. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

Bridgeway Capital Management held 108,005 shares of Fennec Pharmaceuticals worth $1.16M as of Q2 2026.
Bridgeway Capital Management bought 25,000 Fennec Pharmaceuticals shares in Q2 2026, an estimated $204K.
Fennec Pharmaceuticals made up 0.02% of Bridgeway Capital Management's portfolio in Q2 2026, its #711 holding.
Bridgeway Capital Management first reported a position in Fennec Pharmaceuticals in Q4 2022 and has held it in 9 quarters since.
104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.